Supernus Pharmaceuticals, Inc. (SUPN): Revisiting Analysts’ $80 Price Target – The RNS Daily

This post was originally published on this site

Supernus Pharmaceuticals, Inc. (SUPN): Revisiting Analysts’ $80 Price Target  The RNS Daily

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) stock enjoyed an overall uptrend of 1.73% from the beginning of 2018. The closing share price quoted for …

This post was originally published on *this site*